| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff3e741d8c3082a79ba472a5a4c2bef8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2523-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2007-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f1513adbc8ae6457357676a8f84028c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c29260e47681adb364af9f65cdbe475b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_186c6993b085c99637b03f329630bc7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f9e8bec931f25e8cd28c2112b31eca0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90c88cbd8553a1f44021f52d0c127dc7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b6f518560a3593b53495297b9d78fb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17c4d95a386d5f21f502e95356906e48 |
| publicationDate |
2017-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2615354-T3 |
| titleOfInvention |
Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders |
| abstract |
A method for detecting a proliferative disorder of prostate cells in a subject comprising determining the levels of methylation of the RASSF2A gene in an isolated biological sample of said subject, wherein said methylation is determined by detecting the presence or absence of CpG methylation within said gene, and where the presence of CpG methylation is indicative of the presence of said disorder. |
| priorityDate |
2006-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |